Inside EchoNext: The ECG Is Only the Beginning
Dr. Dereck Mush, MD, MBA
Leave Granola and get up to 12 months free of Wispr Flow Notetaker + Dictation
If you have paid time left on an individual Granola plan, we'll match it with a Wispr Flow subscription that includes Notetaker and dictation, and add bonus time, up to 12 months total. Sign in or create a Wispr account and submit proof of your plan to check eligibility.
CARDIOVASCULAR AI
1. EchoNext Earns TIME Recognition for AI Heart Screening
Dr. Pierre Elias, who led the team behind EchoNext. Credit: Courtesy of NewYork-Presbyterian.
Pathway Labs’ EchoNext has joined TIME’s 2026 Best Inventions list. The FDA-cleared tool analyzes routine 12-lead ECGs to flag signs of structural heart disease that may warrant further evaluation.
The details:
A new spotlight on an existing tool. TIME published the recognition on October 15. FDA clearance came on June 8; Pathway’s public launch, OpenEvidence partnership and $8.5M seed announcement followed on June 23.
The evidence spans different studies. NYP’s account of the 2025 Nature study reports 77% detection in a reader comparison, versus 64% for unassisted cardiologists. Separately, external validation reported in FDA’s summary shows 73.7% sensitivity and 75.2% specificity for the combined structural-heart-disease output. Those figures come from different evaluations.
The result points to a next step. EchoNext supports adult assessment using compatible ECGs and excludes patients with implanted pacemakers. Its notification cannot confirm a diagnosis or rule out the need for follow-up.
The Signal: The opportunity is to help clinicians spot patients who need a closer look using a test already in routine care. The service around the alert matters: someone must review it, reach the patient and arrange the appropriate assessment.
CLINICAL RESEARCH
2. Oracle and AstraZeneca Team Up on Clinical Research
AstraZeneca’s research and development centre in Kendall Square, Cambridge, Massachusetts.
Credit: Aram Boghosian / AstraZeneca.
Oracle and AstraZeneca announced a collaboration on October 20 to explore how AI and real-world data can support research and clinical workflows. The first planned programme, with M42 in Abu Dhabi, focuses on hypertension care and research.
The details:
Trial recruitment is a starting point. The companies want to make it easier to identify potentially eligible patients and bring relevant research insights into care. A suggested match still needs eligibility checks and the patient enrollment process.
Projects will proceed individually. The agreement is non-binding, with financial terms undisclosed. Each proposed project requires separate review and appropriate safeguards before implementation.
Patient information has defined boundaries. AstraZeneca says it will not receive patient-identifiable information. The announcement describes the collaboration’s aims; results will depend on the programmes that follow.
The Signal: A trial opportunity is only useful if a suitable patient can reach it. The first programme gives this partnership a concrete test: make the connection between care teams and research teams easier to act on.
HEALTHCARE DATA & INFRASTRUCTURE
3. Artisight’s All-In-One Device Makes TIME’s Best Inventions List
Artisight’s room technology combines sensing, communication and computing to support hospital care workflows. Credit: Courtesy of Artisight.
Artisight’s All-In-One device has also earned a place on TIME’s 2026 list. The company’s October 15 announcement highlights a shared platform for patient rooms and operating rooms, supporting several services through the same infrastructure.
The details:
One platform supports several tasks. Artisight describes virtual nursing, specialty teleconsults, ambient documentation and room workflow coordination among its uses. Hospitals can assess which services fit their teams and existing processes.
Computing happens close to care. The device uses NVIDIA Jetson Orin NX for edge inference. Artisight lists wall, ceiling and clamp mounting, with physical camera and audio controls.
The care model determines the result. The company reports customer efficiency and safety gains. Those results need to be assessed in context; the award does not establish a standard staffing ratio or guarantee fewer falls.
The Signal: Shared technology can simplify the room, but virtual nursing still needs a well-designed service. Clear task ownership and handoffs determine whether remote support makes bedside work easier or gives staff another process to manage.
Related reading
Dr. Dereck Mush, MD, MBA
Perinatal mental health screening is finally getting built into standard obstetric workflows
Dr. Dereck Mush, MD, MBA
Opportunistic Valvular Screening: How Routine ECG-AI Expands the Structural Heart Pipeline
Dr. Dereck Mush, MD, MBA
The preventive screening clinic business model is maturing beyond the walk-in scan
Dr. Dereck Mush, MD, MBAKeep exploring